Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.
Clin Sci (Lond). 2013 Oct;125(7):341-8. doi: 10.1042/CS20120596.
DM (diabetes mellitus) is present in 20-40% of patients with liver cirrhosis, but its prognostic impact is unclear. Therefore, in the present study, we investigated whether the presence of DM in patients with cirrhosis was associated with increased mortality, and/or with increased incidence of SBP (spontaneous bacterial peritonitis). We reviewed medical and laboratory data of 230 patients with cirrhosis from the period 2001-2011, for whom data were complete in n=226. Follow-up for the outcomes mortality and SBP was performed until May 2012, with only 13 patients lost to follow-up. DM was present at baseline in 78 patients (35%). Median follow-up was 6.2 (interquartile range, 3.1-9.3) years, during which 118 patients died [47 out of 78 with DM (60%), and 71 out of 148 without DM (48%)]. The presence of DM at baseline was not associated with increased mortality after adjustment for age {HR (hazard ratio), 1.00 [95% CI (confidence interval), 0.67-1.50]}. Further adjustment for sex, aetiology of cirrhosis, platelet count and the Child-Pugh or MELD (model for end-stage liver disease) score did not change this finding. During follow-up, 37 patients developed incident SBP (19 with DM and 18 without DM). DM at baseline was associated with incident SBP, even after adjustment for age, sex, aetiology, platelet count and the Child-Pugh [HR, 2.39 (95% CI, 1.10-5.18)] or MELD score [HR, 2.50 (95% CI, 1.16-5.40)]. In conclusion, the presence of DM at baseline in patients with cirrhosis was associated with an increased risk of SBP, which may represent an increased susceptibility to infections. On the other hand, DM was not clearly associated with increased mortality in these patients.
糖尿病(DM)在 20-40%的肝硬化患者中存在,但它的预后影响尚不清楚。因此,在本研究中,我们调查了肝硬化患者中 DM 的存在是否与死亡率增加相关,和/或与自发性细菌性腹膜炎(SBP)的发生率增加相关。我们回顾了 2001-2011 年期间 230 例肝硬化患者的医疗和实验室数据,其中 n=226 例数据完整。对死亡率和 SBP 的结局进行了随访,直到 2012 年 5 月,只有 13 例患者失访。78 例患者(35%)在基线时存在 DM。中位随访时间为 6.2 年(四分位距,3.1-9.3),在此期间 118 例患者死亡[78 例 DM 中有 47 例(60%),148 例无 DM 中有 71 例(48%)]。在调整年龄后,基线时存在 DM 与死亡率增加无关{风险比(HR),1.00[95%可信区间(CI),0.67-1.50]}。进一步调整性别、肝硬化病因、血小板计数和 Child-Pugh 或 MELD(终末期肝病模型)评分并没有改变这一发现。在随访期间,37 例患者发生了 SBP(19 例 DM 和 18 例无 DM)。即使在调整年龄、性别、病因、血小板计数和 Child-Pugh[HR,2.39(95%CI,1.10-5.18)]或 MELD 评分[HR,2.50(95%CI,1.16-5.40)]后,基线时的 DM 与 SBP 仍相关。总之,肝硬化患者基线时存在 DM 与 SBP 的风险增加相关,这可能代表对感染的易感性增加。另一方面,DM 与这些患者的死亡率增加并不明显相关。